Tag: P2y2 receptor agonist

Originally approved in Japan in 2010, Diquafosol is a unique treatment for Dry Eye Disease that works by stimulating the natural secretion of tear components directly on the ocular surface. This provides a different approach compared to traditional artificial tears and has demonstrated effectiveness in improving both the signs and symptoms of dry eye. Understanding **what is Diquafosol eye drops used for** is crucial for patients exploring advanced treatment options.

Chronic dry eye disease affects hundreds of millions of people globally, causing significant discomfort and vision impairment. Diquas, a medication containing diquafosol sodium, offers a unique therapeutic approach by activating the body's natural tear secretion pathways to address the root causes of ocular dryness.